Scott McLaurin
Medical · Merced, CANPI 1043545866
Payments from drug & device makers
Across 240 payments — averaging $17.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$705
- Lilly USA, LLC$510
- Bayer$357
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$227
- Biohaven Pharmaceuticals, Inc.$224
- Novo Nordisk$223
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,11699%
- Education$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $705 |
| Lilly USA, LLC | 31 | $510 |
| Bayer | 15 | $357 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $227 |
| Biohaven Pharmaceuticals, Inc. | 8 | $224 |
| Novo Nordisk | 12 | $223 |
| Pfizer | 11 | $215 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $186 |
| Boehringer Ingelheim | 12 | $183 |
| Johnson & Johnson | 8 | $144 |
| GSK | 9 | $143 |
| Esperion Therapeutics, Inc. | 8 | $135 |
| AstraZeneca | 9 | $130 |
| Otsuka America Pharmaceutical, Inc. | 5 | $101 |
| Abbott | 5 | $85 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $73 |
| Astellas Pharma US Inc | 4 | $63 |
| Sanofi-aventis U.S. LLC | 3 | $62 |
| Amgen | 3 | $42 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Idorsia Pharmaceuticals US Inc | 2 | $39 |
| Merck | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Eyevance Pharmaceuticals LLC | 2 | $25 |
| Hikma Pharmaceuticals USA | 2 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Exact Sciences | 1 | $21 |
| Axonics, Inc. | 1 | $21 |
| Halozyme Inc | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Genentech USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$125
How this compares
$4,161 in reported general payments places this provider in the 85th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 44 | $563 |
| Famotidine | 24 | $486 |
| Metoprolol Succinate | 29 | $427 |
| Atorvastatin Calcium | 62 | $335 |
| Olmesartan Medoxomil | 19 | $320 |
| Amlodipine Besylate | 52 | $308 |
| Tamsulosin Hcl | 30 | $296 |
| Omeprazole | 31 | $292 |
| Gabapentin | 23 | $280 |
| Levothyroxine Sodium | 30 | $224 |
| Pravastatin Sodium | 17 | $217 |
| Ezetimibe | 12 | $179 |
| Pantoprazole Sodium | 18 | $176 |
| Lisinopril | 30 | $173 |
| ClopidogrelClopidogrel Bisulfate | 15 | $168 |
Paid to pharmacies, not to this prescriber.
Other medical in Merced
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.